Hence, depending on the physiological context, p38 MAPK activity may lead to harmful consequences of sarcopenia and insulin resistance in the immobile muscle or beneficial effects of increased glucose sensitivity and metabolism in the contracting muscle. The gene discussed is INS; the disease is sarcopenia.